Chris Seto

Chris Seto serves as Chief Executive Officer at Spectral Medical Inc.. Spectral Medical Inc. operates in the research sector with approximately 33.0 employees. The company is headquartered in Toronto, Ontario. Spectral Medical Inc. generates annual revenue of 493000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 3,797 executive contacts are available in Ontario.
• • Our database includes 201,469 c suite-level executives.

Outlook Apache YouTube Mobile Friendly Google Tag Manager Google Font API WordPress.org

biotechnology research endotoxin activity assay eaa sepsis diagnosis septic shock treatment theranostic approach polymyxin b hemoperfusion endotoxin removal diagnostic assay fda cleared ce marked healthcare innovation critical care management systemic inflammation immune response neutrophil activation in vitro absorption blood purification bioassay clinical trials biomarkers for sepsis acute kidney injury extracorporeal therapy multicenter trials risk stratification intensive care unit health outcomes medical device clinical diagnostics biochemical reagents lipopolysaccharide systemic infection detection therapy efficacy patient outcomes improvement precision medicine blood flow management calibration standards inflammation markers hemoadsorption biomedicine therapeutic options evidence-based treatment research applications quality healthcare health economic analysis molecular diagnostics diagnostic testing clinical research regulatory compliance safety monitoring health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Chris Seto in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Spectral Medical Inc..

Chris Seto's Position in the MessageCEO Database

• •Chris Seto is 1 of 1 verified executive contact we track at Spectral Medical Inc..
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •3,711 verified executive contacts in Ontario are in the database.
• •36 verified contacts work at research companies in the 33.0 employee range (same size as Spectral Medical Inc.).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

How do I reach Chris Seto directly?

Chris Seto's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Spectral Medical Inc.. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Chris Seto work for?

Chris Seto is Chief Executive Officer at Spectral Medical Inc., a company in the research sector with 33.0 employees. The company is based in Toronto, Ontario.

Can I pitch or sell to Chris Seto?

As Chief Executive Officer at Spectral Medical Inc., Chris Seto is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Chris Seto directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Chris Seto in?

Chris Seto works in the research industry as Chief Executive Officer at Spectral Medical Inc.. MessageCEO provides verified contact information for executives across all major industries.

Is Chris Seto's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Chris Seto's profile is kept up-to-date with the latest available information.

Last updated: June 25, 2026